SIMILAR PATTERNS OF AMINO ACIDS FOR 1XLX_A_CIOA101_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1js8 | HEMOCYANIN (Enteroctopusdofleini) |
PF00264(Tyrosinase)PF14830(Haemocyan_bet_s) | 5 | HIS A2671LEU A2574THR A2566MET A2564GLN A2561 | CUO A 888 (-3.4A)NoneNoneNoneNone | 1.31A | 1xlxA-1js8A:undetectable | 1xlxA-1js8A:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1m2p | CASEIN KINASE II,ALPHA CHAIN (Zea mays) |
PF00069(Pkinase) | 5 | HIS A 154LEU A 85ILE A 174MET A 163PHE A 113 | NoneNoneHNA A 351 (-3.8A)HNA A 351 ( 3.8A)HNA A 351 (-3.6A) | 1.48A | 1xlxA-1m2pA:undetectable | 1xlxA-1m2pA:19.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1pja | PALMITOYL-PROTEINTHIOESTERASE 2PRECURSOR (Homo sapiens) |
PF02089(Palm_thioest) | 5 | LEU A 195ASN A 177ILE A 175SER A 111GLN A 112 | NoneNoneNoneGOL A1616 (-3.4A)None | 1.31A | 1xlxA-1pjaA:undetectable | 1xlxA-1pjaA:21.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 736HIS A 737HIS A 825THR A 952ILE A 955GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.59A | 1xlxA-1sojA:41.6 | 1xlxA-1sojA:30.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wu2 | MOLYBDOPTERINBIOSYNTHESIS MOEAPROTEIN (Pyrococcushorikoshii) |
PF00994(MoCF_biosynth)PF03453(MoeA_N)PF03454(MoeA_C) | 5 | TYR A 10LEU A 17ILE A 281SER A 297PHE A 287 | None | 1.47A | 1xlxA-1wu2A:undetectable | 1xlxA-1wu2A:21.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zkl | HIGH-AFFINITYCAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 7A (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 211HIS A 212HIS A 256ASN A 365GLN A 413PHE A 416 | IBM A 503 (-4.6A)NoneNoneIBM A 503 ( 4.7A)IBM A 503 (-3.0A)IBM A 503 (-3.4A) | 0.42A | 1xlxA-1zklA:45.3 | 1xlxA-1zklA:34.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1znp | HYPOTHETICAL PROTEINATU3615 (Agrobacteriumfabrum) |
PF06172(Cupin_5) | 5 | TYR A 25HIS A 19THR A 28ILE A 43SER A 40 | None | 1.42A | 1xlxA-1znpA:undetectable | 1xlxA-1znpA:16.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d2a | SUFA PROTEIN (Escherichiacoli) |
PF01521(Fe-S_biosyn) | 5 | HIS A 27LEU A 99ILE A 102SER A 119PHE A 120 | None | 1.32A | 1xlxA-2d2aA:undetectable | 1xlxA-2d2aA:17.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eyu | TWITCHING MOTILITYPROTEIN PILT (Aquifexaeolicus) |
PF00437(T2SSE) | 5 | MET A 218LEU A 140THR A 152ILE A 153SER A 147 | None | 1.43A | 1xlxA-2eyuA:undetectable | 1xlxA-2eyuA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eyu | TWITCHING MOTILITYPROTEIN PILT (Aquifexaeolicus) |
PF00437(T2SSE) | 5 | MET A 218THR A 152ILE A 153SER A 147GLN A 279 | None | 1.47A | 1xlxA-2eyuA:undetectable | 1xlxA-2eyuA:22.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qyk | CYCLIC AMP-SPECIFICPHOSPHODIESTERASEHSPDE4A10 (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 412MET A 485THR A 545GLN A 581PHE A 584 | ZN A 1 (-3.3A)NoneNPV A 3 ( 4.7A)NPV A 3 (-3.1A)NPV A 3 (-3.3A) | 1.44A | 1xlxA-2qykA:52.3 | 1xlxA-2qykA:87.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qyk | CYCLIC AMP-SPECIFICPHOSPHODIESTERASEHSPDE4A10 (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 371HIS A 372HIS A 416MET A 485LEU A 531ASN A 533THR A 545ILE A 548MET A 549SER A 580GLN A 581PHE A 584 | NPV A 3 (-4.4A)NPV A 3 (-4.6A)NoneNoneNoneNPV A 3 (-4.4A)NPV A 3 ( 4.7A)NPV A 3 (-3.8A)NPV A 3 ( 4.7A)NPV A 3 (-4.5A)NPV A 3 (-3.1A)NPV A 3 (-3.3A) | 0.37A | 1xlxA-2qykA:52.3 | 1xlxA-2qykA:87.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 281ASN A 443THR A 455ILE A 458MET A 459 | None | 0.81A | 1xlxA-2qymA:43.2 | 1xlxA-2qymA:75.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 281HIS A 282HIS A 326MET A 395LEU A 441ASN A 443THR A 455ILE A 458PHE A 494 | None | 0.50A | 1xlxA-2qymA:43.2 | 1xlxA-2qymA:75.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r8q | CLASS IPHOSPHODIESTERASEPDEB1 (Leishmaniamajor) |
PF00233(PDEase_I) | 7 | TYR A 680HIS A 681HIS A 725MET A 797ASN A 838GLN A 887PHE A 890 | IBM A 3 ( 4.7A)IBM A 3 ( 4.8A)NoneNoneIBM A 3 (-4.5A)IBM A 3 (-3.3A)IBM A 3 (-3.6A) | 0.64A | 1xlxA-2r8qA:39.7 | 1xlxA-2r8qA:29.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r8q | CLASS IPHOSPHODIESTERASEPDEB1 (Leishmaniamajor) |
PF00233(PDEase_I) | 5 | TYR A 680HIS A 681HIS A 725MET A 797THR A 854 | IBM A 3 ( 4.7A)IBM A 3 ( 4.8A)NoneNoneNone | 1.41A | 1xlxA-2r8qA:39.7 | 1xlxA-2r8qA:29.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3abg | BILIRUBIN OXIDASE (Albifimbriaverrucaria) |
PF07731(Cu-oxidase_2)PF07732(Cu-oxidase_3) | 5 | HIS A 401HIS A 458LEU A 95SER A 127GLN A 126 | CU A 703 (-3.4A) CU A 702 (-3.5A)NoneNoneNone | 1.48A | 1xlxA-3abgA:undetectable | 1xlxA-3abgA:20.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b2r | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 612HIS A 613HIS A 657LEU A 765GLN A 817PHE A 820 | VDN A 1 (-4.8A)VDN A 1 (-4.3A)NoneVDN A 1 ( 4.7A)VDN A 1 (-3.0A)VDN A 1 (-3.6A) | 0.96A | 1xlxA-3b2rA:30.9 | 1xlxA-3b2rA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bjc | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 612HIS A 613HIS A 657LEU A 765GLN A 775 | None MG A 877 (-4.4A) MG A 877 (-4.3A)WAN A 901 ( 4.7A)WAN A 901 ( 4.6A) | 1.23A | 1xlxA-3bjcA:33.6 | 1xlxA-3bjcA:17.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bjc | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 612HIS A 613HIS A 657LEU A 765GLN A 817PHE A 820 | None MG A 877 (-4.4A) MG A 877 (-4.3A)WAN A 901 ( 4.7A)WAN A 901 (-3.1A)WAN A 901 (-3.7A) | 0.60A | 1xlxA-3bjcA:33.6 | 1xlxA-3bjcA:17.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ecn | HIGH AFFINITYCAMP-SPECIFIC ANDIBMX-INSENSITIVE3',5'-CYCLICPHOSPHODIESTERASE 8A (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 555HIS A 556HIS A 600MET A 670ASN A 729ILE A 744SER A 777GLN A 778PHE A 781 | NoneNoneNoneIBM A 3 (-4.5A)NoneIBM A 3 (-4.3A)NoneIBM A 3 (-3.4A)IBM A 3 (-3.5A) | 0.42A | 1xlxA-3ecnA:44.7 | 1xlxA-3ecnA:34.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 330MET A 439LEU A 485SER A 534PHE A 538 | ZN A 801 (-3.4A)D71 A 901 ( 4.0A)NoneD71 A 901 (-3.4A)D71 A 901 (-3.9A) | 1.38A | 1xlxA-3g4gA:51.0 | 1xlxA-3g4gA:66.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 6 | HIS A 330MET A 439LEU A 485THR A 499GLN A 535PHE A 538 | ZN A 801 (-3.4A)D71 A 901 ( 4.0A)NoneD71 A 901 (-3.6A)D71 A 901 (-3.1A)D71 A 901 (-3.9A) | 1.35A | 1xlxA-3g4gA:51.0 | 1xlxA-3g4gA:66.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 8 | HIS A 370MET A 439LEU A 485ASN A 487ILE A 502MET A 503SER A 534PHE A 538 | NoneD71 A 901 ( 4.0A)NoneD71 A 901 (-4.5A)D71 A 901 (-4.1A)D71 A 901 (-3.6A)D71 A 901 (-3.4A)D71 A 901 (-3.9A) | 0.88A | 1xlxA-3g4gA:51.0 | 1xlxA-3g4gA:66.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 9 | HIS A 370MET A 439LEU A 485ASN A 487THR A 499ILE A 502MET A 503GLN A 535PHE A 538 | NoneD71 A 901 ( 4.0A)NoneD71 A 901 (-4.5A)D71 A 901 (-3.6A)D71 A 901 (-4.1A)D71 A 901 (-3.6A)D71 A 901 (-3.1A)D71 A 901 (-3.9A) | 0.70A | 1xlxA-3g4gA:51.0 | 1xlxA-3g4gA:66.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 325HIS A 326HIS A 370LEU A 485ASN A 487ILE A 502MET A 503SER A 534PHE A 538 | NoneD71 A 901 (-4.5A)NoneNoneD71 A 901 (-4.5A)D71 A 901 (-4.1A)D71 A 901 (-3.6A)D71 A 901 (-3.4A)D71 A 901 (-3.9A) | 0.66A | 1xlxA-3g4gA:51.0 | 1xlxA-3g4gA:66.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 10 | TYR A 325HIS A 326HIS A 370LEU A 485ASN A 487THR A 499ILE A 502MET A 503GLN A 535PHE A 538 | NoneD71 A 901 (-4.5A)NoneNoneD71 A 901 (-4.5A)D71 A 901 (-3.6A)D71 A 901 (-4.1A)D71 A 901 (-3.6A)D71 A 901 (-3.1A)D71 A 901 (-3.9A) | 0.47A | 1xlxA-3g4gA:51.0 | 1xlxA-3g4gA:66.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hoc | FILAMIN-A (Homo sapiens) |
PF00307(CH) | 5 | LEU A 172THR A 186ILE A 185SER A 189PHE A 188 | None | 1.34A | 1xlxA-3hocA:undetectable | 1xlxA-3hocA:22.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i2t | EPIDERMAL GROWTHFACTOR RECEPTOR,ISOFORM A (Drosophilamelanogaster) |
PF00757(Furin-like)PF01030(Recep_L_domain)PF14843(GF_recep_IV) | 5 | MET A 418LEU A 406ASN A 373ILE A 330SER A 412 | None | 1.31A | 1xlxA-3i2tA:undetectable | 1xlxA-3i2tA:24.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ibj | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I)PF01590(GAF)PF13185(GAF_2) | 7 | TYR A 655HIS A 656HIS A 700LEU A 809ILE A 826GLN A 859PHE A 862 | None | 0.99A | 1xlxA-3ibjA:32.5 | 1xlxA-3ibjA:19.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n3z | HIGH AFFINITYCGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 9A (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 252HIS A 296MET A 365ASN A 405GLN A 453 | NoneNoneNoneIBM A 1 (-3.5A)IBM A 1 (-3.5A) | 0.83A | 1xlxA-3n3zA:41.1 | 1xlxA-3n3zA:30.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n3z | HIGH AFFINITYCGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 9A (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 252HIS A 296MET A 365GLN A 453PHE A 456 | NoneNoneNoneIBM A 1 (-3.5A)IBM A 1 (-3.4A) | 0.63A | 1xlxA-3n3zA:41.1 | 1xlxA-3n3zA:30.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o57 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 274MET A 347THR A 407GLN A 443PHE A 446 | ZN A 1 (-3.3A)ZG2 A 506 (-3.9A)ZG2 A 506 (-4.3A)ZG2 A 506 (-3.3A)ZG2 A 506 (-3.6A) | 1.47A | 1xlxA-3o57A:53.5 | 1xlxA-3o57A:93.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o57 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 233HIS A 234HIS A 278MET A 347LEU A 393ASN A 395THR A 407ILE A 410MET A 411SER A 442GLN A 443PHE A 446 | NoneNoneNoneZG2 A 506 (-3.9A)NoneZG2 A 506 (-4.3A)ZG2 A 506 (-4.3A)ZG2 A 506 (-4.4A)NoneNoneZG2 A 506 (-3.3A)ZG2 A 506 (-3.6A) | 0.55A | 1xlxA-3o57A:53.5 | 1xlxA-3o57A:93.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qi3 | HIGH AFFINITYCGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 9A (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 252HIS A 296MET A 365ASN A 405PHE A 456 | PDB A 600 (-4.6A)NonePDB A 600 ( 4.7A)PDB A 600 (-4.4A)PDB A 600 (-3.5A) | 0.54A | 1xlxA-3qi3A:41.5 | 1xlxA-3qi3A:26.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rst | SIGNAL PEPTIDEPEPTIDASE SPPA (Bacillussubtilis) |
PF01343(Peptidase_S49) | 5 | TYR A 84HIS A 86LEU A 107ILE A 69SER A 147 | None | 1.46A | 1xlxA-3rstA:undetectable | 1xlxA-3rstA:20.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 315LEU A 399THR A 333SER A 368GLN A 369 | HIS A 315 ( 1.0A)LEU A 399 ( 0.6A)THR A 333 ( 0.8A)SER A 368 (-0.0A)GLN A 369 (-0.6A) | 1.31A | 1xlxA-3sl5A:51.0 | 1xlxA-3sl5A:84.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 159HIS A 160HIS A 204MET A 273LEU A 319ASN A 321THR A 333ILE A 336MET A 337SER A 368GLN A 369PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)HIS A 204 ( 1.0A)MET A 273 (-0.0A)LEU A 319 ( 0.6A)ASN A 321 (-0.6A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 337 ( 0.0A)SER A 368 (-0.0A)GLN A 369 (-0.6A)PHE A 372 (-1.3A) | 0.54A | 1xlxA-3sl5A:51.0 | 1xlxA-3sl5A:84.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tqg | 2-METHYLCITRATESYNTHASE (Coxiellaburnetii) |
PF00285(Citrate_synt) | 5 | TYR A 315LEU A 307ASN A 222THR A 326ILE A 328 | None | 1.47A | 1xlxA-3tqgA:undetectable | 1xlxA-3tqgA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ui7 | CAMP ANDCAMP-INHIBITED CGMP3',5'-CYCLICPHOSPHODIESTERASE10A (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 524HIS A 525HIS A 567LEU A 675ILE A 692GLN A 726PHE A 729 | C1L A 1 ( 4.8A)C1L A 1 (-4.1A)NoneC1L A 1 (-4.3A)C1L A 1 (-4.3A)C1L A 1 (-2.9A)C1L A 1 (-3.5A) | 0.91A | 1xlxA-3ui7A:38.0 | 1xlxA-3ui7A:27.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3v94 | CYCLIC NUCLEOTIDESPECIFICPHOSPHODIESTERASE (Trypanosomacruzi) |
PF00233(PDEase_I) | 6 | TYR A 367HIS A 368HIS A 413ILE A 538GLN A 570PHE A 573 | WYQ A 701 (-4.5A)NoneNoneWYQ A 701 ( 4.1A)WYQ A 701 (-3.3A)WYQ A 701 (-3.4A) | 0.43A | 1xlxA-3v94A:40.1 | 1xlxA-3v94A:27.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3v94 | CYCLIC NUCLEOTIDESPECIFICPHOSPHODIESTERASE (Trypanosomacruzi) |
PF00233(PDEase_I) | 6 | TYR A 367HIS A 413MET A 482ILE A 538GLN A 570PHE A 573 | WYQ A 701 (-4.5A)NoneWYQ A 701 (-4.5A)WYQ A 701 ( 4.1A)WYQ A 701 (-3.3A)WYQ A 701 (-3.4A) | 0.85A | 1xlxA-3v94A:40.1 | 1xlxA-3v94A:27.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bn5 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-3,MITOCHONDRIAL (Homo sapiens) |
PF02146(SIR2) | 5 | LEU A 347ASN A 344THR A 320ILE A 317MET A 143 | NoneCNA A1395 (-3.3A)CNA A1395 (-4.2A)NoneNone | 1.45A | 1xlxA-4bn5A:undetectable | 1xlxA-4bn5A:19.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fzv | PUTATIVEMETHYLTRANSFERASENSUN4 (Homo sapiens) |
PF01189(Methyltr_RsmB-F) | 5 | HIS A 105LEU A 164THR A 342SER A 356PHE A 354 | None | 1.41A | 1xlxA-4fzvA:undetectable | 1xlxA-4fzvA:21.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hl6 | UNCHARACTERIZEDPROTEIN YFDE (Escherichiacoli) |
PF02515(CoA_transf_3) | 5 | MET A 106LEU A 97ILE A 119SER A 85PHE A 87 | None | 1.36A | 1xlxA-4hl6A:undetectable | 1xlxA-4hl6A:24.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4htz | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 655HIS A 656HIS A 700LEU A 809ILE A 826GLN A 859PHE A 862 | None | 0.67A | 1xlxA-4htzA:38.7 | 1xlxA-4htzA:27.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 6 | TYR A 668HIS A 669HIS A 713MET A 785ASN A 825GLN A 874 | None | 0.67A | 1xlxA-4i15A:38.9 | 1xlxA-4i15A:31.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 6 | TYR A 668HIS A 669HIS A 713MET A 785ASN A 825PHE A 877 | None | 0.52A | 1xlxA-4i15A:38.9 | 1xlxA-4i15A:31.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 5 | TYR A 668HIS A 669HIS A 713MET A 785THR A 841 | None | 1.45A | 1xlxA-4i15A:38.9 | 1xlxA-4i15A:31.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j8b | COATOMER ALPHASUBUNIT (Schizosaccharomycespombe) |
PF00400(WD40) | 5 | HIS A 255LEU A 326THR A 305ILE A 304PHE A 324 | None | 1.21A | 1xlxA-4j8bA:undetectable | 1xlxA-4j8bA:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kwb | SIGNAL PEPTIDEPEPTIDASE SPPA (Bacillussubtilis) |
PF01343(Peptidase_S49) | 5 | TYR A 84HIS A 86LEU A 107ILE A 69SER A 147 | None | 1.45A | 1xlxA-4kwbA:undetectable | 1xlxA-4kwbA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q8g | PAB-DEPENDENTPOLY(A)-SPECIFICRIBONUCLEASE SUBUNITPAN2 (Saccharomycescerevisiae) |
PF13423(UCH_1) | 5 | MET A 703LEU A 735ILE A 695SER A 773PHE A 760 | None | 1.07A | 1xlxA-4q8gA:undetectable | 1xlxA-4q8gA:19.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r58 | LEUCINE RICH REPEATPROTEIN (syntheticconstruct) |
PF12354(Internalin_N)PF12799(LRR_4)PF13516(LRR_6) | 5 | LEU A 180ASN A 183THR A 142ILE A 141SER A 145 | None | 1.41A | 1xlxA-4r58A:undetectable | 1xlxA-4r58A:19.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r58 | LEUCINE RICH REPEATPROTEIN (syntheticconstruct) |
PF12354(Internalin_N)PF12799(LRR_4)PF13516(LRR_6) | 5 | LEU A 202ASN A 205THR A 164ILE A 163SER A 167 | None | 1.44A | 1xlxA-4r58A:undetectable | 1xlxA-4r58A:19.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 405HIS A 406HIS A 450MET A 519LEU A 565ASN A 567THR A 579ILE A 582MET A 583SER A 614GLN A 615PHE A 618 | None MG A 804 ( 4.9A)NoneNoneNoneNoneNoneNoneNoneNoneNoneNone | 0.65A | 1xlxA-4wziA:52.1 | 1xlxA-4wziA:61.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xuk | PUTATIVE HYDROLASE (Acinetobactersp. NBRC 100985) |
PF00753(Lactamase_B) | 5 | HIS A 160HIS A 155LEU A 313THR A 70ILE A 105 | ZN A 401 (-3.2A) ZN A 402 (-3.5A)NoneNoneNone | 1.37A | 1xlxA-4xukA:undetectable | 1xlxA-4xukA:20.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zo3 | ACYLHOMOSERINELACTONASE (Chryseobacteriumsp. StRB126) |
PF00753(Lactamase_B) | 5 | HIS A 150HIS A 145ASN A 96THR A 56ILE A 95 | ZN A 402 (-3.2A) ZN A 401 (-3.3A)NoneNoneNone | 1.38A | 1xlxA-4zo3A:undetectable | 1xlxA-4zo3A:23.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b25 | CALCIUM/CALMODULIN-DEPENDENT3',5'-CYCLICNUCLEOTIDEPHOSPHODIESTERASE 1B (Homo sapiens) |
PF00233(PDEase_I) | 8 | TYR A 222HIS A 223HIS A 267MET A 336THR A 385SER A 420GLN A 421PHE A 424 | None4QJ A 603 ( 4.9A)None4QJ A 603 ( 3.9A)None4QJ A 603 (-4.7A)4QJ A 603 (-3.0A)4QJ A 603 (-3.5A) | 0.67A | 1xlxA-5b25A:44.0 | 1xlxA-5b25A:35.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ehk | LANTIBIOTICDEHYDRATASE (Microbisporacorallina) |
PF04738(Lant_dehydr_N)PF14028(Lant_dehydr_C) | 5 | HIS A 183LEU A 212ILE A 283SER A 595GLN A 201 | None | 1.38A | 1xlxA-5ehkA:undetectable | 1xlxA-5ehkA:16.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 7 | TYR A 668HIS A 669HIS A 713MET A 785ASN A 826GLN A 875PHE A 878 | LLN A1003 ( 4.8A)NoneNoneLLN A1003 (-4.0A)LLN A1003 (-4.4A)LLN A1003 (-3.0A)LLN A1003 (-3.8A) | 0.43A | 1xlxA-5h2rA:39.6 | 1xlxA-5h2rA:32.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 5 | TYR A 668HIS A 669HIS A 713MET A 785THR A 842 | LLN A1003 ( 4.8A)NoneNoneLLN A1003 (-4.0A)LLN A1003 (-3.6A) | 1.42A | 1xlxA-5h2rA:39.6 | 1xlxA-5h2rA:32.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kr6 | 4-AMINOBUTYRATETRANSAMINASE (Pseudomonas) |
PF00202(Aminotran_3) | 5 | HIS A 275LEU A 256THR A 285ILE A 284GLN A 127 | None | 1.45A | 1xlxA-5kr6A:undetectable | 1xlxA-5kr6A:24.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lnk | MITOCHONDRIALCOMPLEX I, ND5SUBUNIT (Ovis aries) |
PF00361(Proton_antipo_M)PF00662(Proton_antipo_N)PF06455(NADH5_C) | 5 | LEU L 247THR L 97ILE L 100MET L 101PHE L 124 | None | 1.41A | 1xlxA-5lnkL:undetectable | 1xlxA-5lnkL:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mov | CASEIN KINASE IISUBUNIT ALPHA (Homo sapiens) |
PF00069(Pkinase) | 5 | HIS A 154LEU A 85ILE A 174MET A 163PHE A 113 | NoneNoneHC4 A 401 ( 3.7A)HC4 A 401 ( 4.0A)HC4 A 401 (-3.4A) | 1.49A | 1xlxA-5movA:undetectable | 1xlxA-5movA:24.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mqc | VP1VP3 (Black queencell virus) |
PF08762(CRPV_capsid)no annotation | 5 | HIS C 113MET C 120LEU A 47ASN A 43PHE A 41 | None | 1.38A | 1xlxA-5mqcC:undetectable | 1xlxA-5mqcC:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 5 | HIS A 446MET A 519THR A 579GLN A 615PHE A 618 | ZN A 699 (-3.2A)9VE A 801 (-3.8A)9VE A 801 (-4.1A)9VE A 801 (-3.2A)9VE A 801 (-3.9A) | 1.43A | 1xlxA-5ohjA:52.6 | 1xlxA-5ohjA:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 12 | TYR A 405HIS A 406HIS A 450MET A 519LEU A 565ASN A 567THR A 579ILE A 582MET A 583SER A 614GLN A 615PHE A 618 | NoneNoneNone9VE A 801 (-3.8A)9VE A 801 (-4.7A)9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 ( 4.0A)9VE A 801 (-4.7A)9VE A 801 (-3.2A)9VE A 801 (-3.9A) | 0.36A | 1xlxA-5ohjA:52.6 | 1xlxA-5ohjA:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vyd | PHOSPHODIESTERASE (Salpingoecarosetta) |
no annotation | 6 | HIS A 83HIS A 126MET A 195LEU A 237ASN A 239PHE A 291 | None | 0.71A | 1xlxA-5vydA:40.4 | 1xlxA-5vydA:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 5 | HIS A 200MET A 273THR A 333GLN A 369PHE A 372 | ZN A 602 (-3.3A)AKJ A 601 ( 3.9A)AKJ A 601 (-4.1A)AKJ A 601 (-3.0A)AKJ A 601 (-4.1A) | 1.49A | 1xlxA-5wh6A:52.2 | 1xlxA-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 12 | TYR A 159HIS A 160HIS A 204MET A 273LEU A 319ASN A 321THR A 333ILE A 336MET A 337SER A 368GLN A 369PHE A 372 | AKJ A 601 ( 4.7A)NoneNoneAKJ A 601 ( 3.9A)AKJ A 601 ( 4.6A)AKJ A 601 (-4.3A)AKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 ( 3.7A)AKJ A 601 (-2.5A)AKJ A 601 (-3.0A)AKJ A 601 (-4.1A) | 0.43A | 1xlxA-5wh6A:52.2 | 1xlxA-5wh6A:undetectable |